Spectrophotometric and chromatographic determination of omeprazole in pharmaceutical formulations

被引:5
作者
Gallardo, V. [1 ]
Lopez-Viota, M. [1 ]
Sierra, J. [1 ]
Ruiz, M. A. [1 ]
机构
[1] Univ Granada, Fac Pharm, Dept Pharm & Pharmaceut Technol, Sch Pharm, E-18071 Granada, Spain
关键词
Omeprazole; antacids; SDS; oral suspensions; ZOLLINGER-ELLISON SYNDROME; ACID-RELATED DISORDERS; INTRAVENOUS OMEPRAZOLE; DUODENAL-ULCER; STABILITY; RATS; DISEASE;
D O I
10.1080/10837450902814172
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was to determine the stability of the pH sensitive drug, omeprazole, within different solid oral pharmaceutical formulations and to determine whether the addition of antacid and surfactant agents, at varying concentrations, influenced drug stability and release. Spectrophotometric and chromatographic techniques were used for evaluation purposes, giving good results concerning linearity, precision and specificity within the range of concentrations used in this study. However, the results show that the degradation products of omeprazole interfere with spectrophotometric evaluation, making this technique insufficiently selective for omeprazole. On the other hand, liquid chromotography proved to be more sensitive, accurate and precise. Additionally, in an attempt to improve the administration form of the drug, an extemporaneous suspension was designed, which after evaluation proved to be a satisfactory administration vehicle. The best formulation of omeprazole studied is: omeprazole: 0.5%; corn starch 34.2%; aluminum hydroxide 26%; magnesium hydroxide 13%; simple syrup 24.8%; SDS 1%.
引用
收藏
页码:516 / 523
页数:8
相关论文
共 26 条
[1]  
Alaa EG, 2003, J PHARMACEUT BIOMED, V31, P229
[2]  
BLANCHI A, 1982, LANCET, V2, P1223
[3]   Comparison of derivative spectrophotometric and liquid chromatograpic methods for the determination of omeprazole in aqueous solutions during stability studies [J].
Castro, D ;
Moreno, MA ;
Torrado, S ;
Lastres, JL .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 21 (02) :291-298
[4]   OMEPRAZOLE - A PRELIMINARY REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN PEPTIC-ULCER DISEASE AND ZOLLINGER-ELLISON SYNDROME [J].
CLISSOLD, SP ;
CAMPOLIRICHARDS, DM .
DRUGS, 1986, 32 (01) :15-47
[5]  
DAE YL, 2007, J PHARM PHARM SCI, V10, P420
[6]   A STUDY OF THE ELECTROKINETIC AND STABILITY PROPERTIES OF NITROFURANTOIN SUSPENSIONS .2. FLOCCULATION AND REDISPERSION PROPERTIES AS COMPARED WITH THEORETICAL INTERACTION ENERGY CURVES [J].
DELGADO, A ;
GALLARDO, V ;
PARERA, A ;
GONZALEZCABALLERO, F .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1990, 79 (08) :709-715
[7]   Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes [J].
DiGiacinto, JL ;
Olsen, KM ;
Bergman, KL ;
Hole, EB .
ANNALS OF PHARMACOTHERAPY, 2000, 34 (05) :600-605
[8]  
GALLARDO V, 2000, PHARM EMULSIONS SUSP, P409
[9]   Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease [J].
Hatlebakk, JG ;
Berstad, A .
CLINICAL PHARMACOKINETICS, 1996, 31 (05) :386-406
[10]  
HOFFMANN KJ, 1986, DRUG METAB DISPOS, V14, P341